tislelizumab MeSH Supplementary Concept Data 2024

Details
Concepts

MeSH Supplementary: tislelizumab
Unique ID: C000707970
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000707970
Entry Term(s): BGB-A317
Pharm Action: Antineoplastic Agents, Immunological
Registry Number: 0KVO411B3N
Heading Mapped to: *Antibodies, Monoclonal, Humanized
Frequency: 53
Note: a humanized anti-PD-1 monoclonal antibody
Source: Lancet Oncol. 2019 Sep;20(9):1306-1315.
Date of Entry: 2020/06/30
Revision Date: 2021/10/27

tislelizumab Preferred

BGB-A317 Narrower

page delivered in 0.004s